Inactief instrument

Koers Cubist Pharmaceuticals Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Cubist Pharmaceuticals : Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market	13-01-15
Cubist Pharmaceuticals : meldet FDA-Zulassung seines neuen Antibiotikums ZERBAXA™ (Ceftolozan/Tazobactam) für komplizierte Harnwegsinfektionen und komplizierte intraabdominelle Infektionen	21-12-14
Cubist Pharmaceuticals : annonce l’approbation par la FDA du nouvel antibiotique ZERBAXA™ (ceftolozane/tazobactam) pour le traitement des infections urinaires compliquées et des infections intra-abdominales compliquées	20-12-14
Cubist Pharmaceuticals : Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract and Complicated Intra-abdominal Infections	20-12-14
Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug	10-12-14

Managers	Titel	Leeftijd	Van
Karen Rogers PRN	Corporate Officer/Principal	-	-
Phyllis Rae Abbuhl SAM	Sales & Marketing	-	-
Frederick B. Oleson PRN	Corporate Officer/Principal	-	01-01-97

Besturend	Titel	Leeftijd	Van
Martin Hermanus Soeters BRD	Director/Board Member	70	01-09-06
Kenneth J. Martin BRD	Director/Board Member	70	25-09-13

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	+0,10%	91,42 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	41,08 mld.
BIOGEN INC.	-9,06%	34,26 mld.
UCB	+54,31%	25,27 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,61%	15,27 mld.
INCYTE CORPORATION	-9,14%	12,81 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,11%	11,6 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,61%	11,42 mld.
SWEDISH ORPHAN BIOVITRUM AB	+6,07%	9,16 mld.